A Blood Test To Determine When Antibiotics Are Warranted

Scientists can assay gene activity to distinguish between bacterial and viral infections.

Written byAlison F. Takemura
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Methicillin-resistant Staphyloccus aureus being ingested by neutrophilNIHScientists can distinguish between a viral and a bacterial infection by assaying just seven human genes, according to a study published this week (July 6) in Science Translational Medicine. A clinical test based on these findings would enable doctors to more appropriately prescribe antibiotics, which are ineffective against viruses.

This May, US Centers for Disease Control and Prevention (CDC) reported that doctors prescribe antibiotics when they’re not needed in around 30 percent of cases examined. Overuse of these drugs may promote more widespread antibiotic resistance.

To address the problem, scientists at Stanford University looked at more than 1,000 patient blood samples to identify gene activation signatures associated with either bacterial or viral infections.

The researchers found they could distinguish these two classes of infections by analyzing the expression of seven genes alone. “The notion that there are just seven targets with really excellent accuracy was pretty shocking,” study coauthor Tim Sweeney told Time. The team was then able to validate this seven-gene assay with blood collected from 96 children with sepsis.

“Our test can ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies